Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypercholesterolemia: HELP
Ransi Somaratne
Based on 13 articles published since 2007
||||
Expertise Level
The expertise of Ransi Somaratne ranks in the
  • Top 0.14%
  • ... of 30,216 published authors worldwide on Hypercholesterolemia
  • ... from 2007 through 2018
  • ... based on contributions to 13 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Work Locations
Details
Most likely:    Miscellaneous institutions in Thousand Oaks      
2017
  • Amgen Inc, Thousand Oaks, CA, USA. · Current affiliation: AbbVie, North Chicago, IL, USA. · Current affiliation: BioMarin Pharmaceuticals, Novato, CA, USA. · Current affiliation: Quantitative Solutions, a Certara Company, Seattle, WA, USA. · Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, ┬áSouth Africa. · Pubmed 27861991
  • Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK. Electronic address: · CGH Medical Center, Sterling, Illinois; Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland. · Division of Lipidology, Department of Medicine, University of Cape Town, South Africa. · Jacksonville Center for Clinical Research, Jacksonville, Florida. · Cardiovascular Research Group, School of Biomedicine, University of Manchester, Manchester, UK. · Amgen Inc., Thousand Oaks, California. · Amgen Ltd., Cambridge, UK. · MRC Population Health Research Unit, Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK. Electronic address: · Pubmed 28844508
2016
  • Amgen Inc., Thousand Oaks, CA. · Amgen Ltd., Uxbridge, United Kingdom. · Pubmed 27707817
  • Cleveland Clinic, Cleveland, Ohio. · University of Amsterdam Faculty of Medicine, Amsterdam, the Netherlands. · Amgen Inc, Thousand Oaks, California. · School of Medicine at Mount Sinai, New York, New York. · Flinders University, Bedford Park, SA, Australia. · University of Glasgow, Glasgow, United Kingdom. · Clinical Trial Service Unit, University of Oxford, Oxford, United Kingdom8Epidemiological Services Unit, University of Oxford, Oxford, United Kingdom. · University Hospital of Paris 6, Paris, France. · Charles University in Prague, Prague, Czech Republic11General University Hospital in Prague, Prague, Czech Republic. · David Geffen School of Medicine at the University of California, Los Angeles. · Baylor College of Medicine, Houston, Texas. · Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany. · Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio. · Pubmed 27039291
2014
  • Department of Epidemiology, College of Public Health, University of Iowa, Iowa City2Department of Medicine, College of Public Health, University of Iowa, Iowa City. · Center for Clinical and Basic Research, Aalborg, Denmark. · Division of Cardiovascular Disease, University of Alabama Medical Center, Birmingham. · Department of Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami. · Orange County Research Center, Tustin, California. · Hampton Roads Center for Clinical Research, Suffolk, Virginia. · Amgen Inc, Thousand Oaks, California. · Maine Research Associates, Auburn. · Pubmed 24825642
  • TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Division of Cardiovascular Medicine, University of California at San Francisco, San Francisco, California. · Amgen, Inc., Thousand Oaks, California. · TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: · Pubmed 24161333
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 13 total) written by Ransi Somaratne about Hypercholesterolemia:

  • Impact of Target-Mediated Elimination on the Dose and Regimen of Evolocumab, a Human Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9). 2017
  • Effect of the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Evolocumab on Glycemia, Body Weight, and New-Onset Diabetes Mellitus. 2017
  • Effect of evolocumab on cholesterol synthesis and absorption. 2016
  • Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial. 2016
  • Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. 2015
  • Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial. 2014
  • Rationale and design of LAPLACE-2: a phase 3, randomized, double-blind, placebo- and ezetimibe-controlled trial evaluating the efficacy and safety of evolocumab in subjects with hypercholesterolemia on background statin therapy. 2014
  • AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57). 2014
  • Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial. 2014
  • Safety and effect of very low levels of low-density lipoprotein cholesterol on cardiovascular events. 2013
Show List of Full Article Records
Google Searches

Learn more about Ransi Somaratne using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous institutions in Thousand Oaks
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous institutions in Thousand Oaks
2017
  • Amgen Inc, Thousand Oaks, CA, USA. · Current affiliation: AbbVie, North Chicago, IL, USA. · Current affiliation: BioMarin Pharmaceuticals, Novato, CA, USA. · Current affiliation: Quantitative Solutions, a Certara Company, Seattle, WA, USA. · Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, ┬áSouth Africa. · Pubmed 27861991
  • Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK. Electronic address: · CGH Medical Center, Sterling, Illinois; Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland. · Division of Lipidology, Department of Medicine, University of Cape Town, South Africa. · Jacksonville Center for Clinical Research, Jacksonville, Florida. · Cardiovascular Research Group, School of Biomedicine, University of Manchester, Manchester, UK. · Amgen Inc., Thousand Oaks, California. · Amgen Ltd., Cambridge, UK. · MRC Population Health Research Unit, Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK. Electronic address: · Pubmed 28844508
2016
  • Amgen Inc., Thousand Oaks, CA. · Amgen Ltd., Uxbridge, United Kingdom. · Pubmed 27707817
  • Cleveland Clinic, Cleveland, Ohio. · University of Amsterdam Faculty of Medicine, Amsterdam, the Netherlands. · Amgen Inc, Thousand Oaks, California. · School of Medicine at Mount Sinai, New York, New York. · Flinders University, Bedford Park, SA, Australia. · University of Glasgow, Glasgow, United Kingdom. · Clinical Trial Service Unit, University of Oxford, Oxford, United Kingdom8Epidemiological Services Unit, University of Oxford, Oxford, United Kingdom. · University Hospital of Paris 6, Paris, France. · Charles University in Prague, Prague, Czech Republic11General University Hospital in Prague, Prague, Czech Republic. · David Geffen School of Medicine at the University of California, Los Angeles. · Baylor College of Medicine, Houston, Texas. · Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany. · Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio. · Pubmed 27039291
2014
  • Department of Epidemiology, College of Public Health, University of Iowa, Iowa City2Department of Medicine, College of Public Health, University of Iowa, Iowa City. · Center for Clinical and Basic Research, Aalborg, Denmark. · Division of Cardiovascular Disease, University of Alabama Medical Center, Birmingham. · Department of Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami. · Orange County Research Center, Tustin, California. · Hampton Roads Center for Clinical Research, Suffolk, Virginia. · Amgen Inc, Thousand Oaks, California. · Maine Research Associates, Auburn. · Pubmed 24825642
  • TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Division of Cardiovascular Medicine, University of California at San Francisco, San Francisco, California. · Amgen, Inc., Thousand Oaks, California. · TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: · Pubmed 24161333
10 Other Locations Show
Yearly article counts 022142200000
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.